To produce medicines with more value and better outcomes, patient engagement and insight is vital. It’s the bedrock of the solutions and services we develop at Prime Global.
To supercharge our insight-driven and patient-centred services, we’ve come together with Xperiome to transform solutions and outcomes for patients with rare diseases.
Xperiome is a global healthtech company specialising in rare disease. It provides deep patient insights, from patient recorded outcomes (PROs) to real world evidence (RWE) and more, to deliver innovative new therapies faster and smarter for the pharmaceutical industry.
Xperiome helps us access patients with rare diseases through Raremark, their data-driven knowledge bank of the rare experience, which supports rare patients by providing a community to crowdsource wisdom, a library to catalogue the lived experience, and a matching engine to find research opportunities.